Skip to content

Fixating the Plate of Ahmed Valve to the Sclera Using a Flanged Prolene Suture

Novel Technique for Fixating the Plate of Ahmed Valve to the Sclera Using a Single Flanged Prolene Suture

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06722794
Enrollment
40
Registered
2024-12-09
Start date
2024-06-01
Completion date
2024-10-31
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

Ahmed glaucoma valve, prolene, glaucoma drainage device

Brief summary

this study evaluated new technique for suturing the Ahmed valve device used to treat resistant types of glaucoma

Detailed description

This technique of fixating Ahmed glaucoma valve using flanged prolene suture is an safe, fast, and reproducible technique combines the benefits of fixing the plate with excellent stability with no complications of free plate techniques at the same time, decreasing both the risks of old valve plate fixation techniques and the concerns of the relative technical difficulty

Interventions

PROCEDURENovel Technique for Fixating the Plate of Ahmed Valve to the Sclera Using a Single Flanged Prolene Suture

This novel technique of fixating the plate of Ahmed glaucoma valve to the sclera using a single flanged prolene suture is an efficient, safe, fast, and reproducible technique that combines the benefits of both fixing the plate providing excellent stability without the complications of free plate techniques and at the same time, minimizing both the risks of conventional old valve plate fixation techniques and the concerns of the relative technical difficulty of suturing due to the difficult access to the posterior globe

Sponsors

Magrabi Eye & Ear Hospital
CollaboratorOTHER
Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with IOP more than 21 mmHg , evidence of progressive optic nerve damage, retinal nerve fiber layer defects or typical glaucomatous visual field defects despite maximal tolerable medical or laser treatment are scheduled for surgery.

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frameDescription
long term stability and plate migration3 monthsABSENT MOVEMENT OF THE PLATE WITH NO OTHER COMPLICATIONS

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026